Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13221154 | 0.88 | TDP1 (0.62) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL20721914 | 0.83 | TDP1 (0.52) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL28926873 | 0.82 | TDP1 (0.56) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL6977513 | 0.78 | TDP1 (0.62) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL678566 | 0.78 | TDP1 (0.62) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL24759814 | 0.77 | TDP1 (0.50) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL17361336 | 0.77 | TDP1 (0.50) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL17361335 | 0.77 | TDP1 (0.50) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL19183375 | 0.71 | TDP1 (1.00) | TDP1RECQLMAPTCYP1A2CYP2C19 | |
| SCHEMBL3514654 | 0.71 | TDP1 (0.60) | TDP1RECQLMAPTCYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240090312-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-14 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| EP-3783006-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-3444258-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2020-07-01 | — | — | EP | disclosed |
| EP-3444258-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2019-02-20 | — | — | EP | disclosed |
| EP-3444258-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2019-02-20 | — | — | EP | disclosed |
| US-20190051845-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-02-14 | — | — | US | disclosed |
| US-20190051845-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744142-B2 | Organic electroluminescent materials and devices | TLL1, TLL2, ALPL | TDP1 1375/4885RECQL 1079/4885MAPT 2307/4885 |
| US-20240090312-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TLL1, TLL2, ALPL | TDP1 1375/4885RECQL 1079/4885MAPT 2307/4885 |
| US-20190051845-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TLL1, TLL2, ALPL | TDP1 1375/4885RECQL 1079/4885MAPT 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.